10-Q: Innventure Reports Q3 Results Amidst Goodwill Impairment

Innventure, Inc. disclosed substantial goodwill impairment charges and significant net losses for the third quarter of 2026, while also highlighting revenue growth and strategic repositioning efforts.

Summary

• Innventure, Inc. reported a net loss of $333.8 million for the three months ended September 30, 2026, compared to a net loss of $34.7 million for the same period in 2025.
• For the nine months ended September 30, 2026, the net loss was $396.5 million, compared to $429.7 million in the prior year.
• Revenue for the three months ended September 30, 2026, increased to $1.5 million from $0.5 million in the prior year.
• Revenue for the nine months ended September 30, 2026, increased to $3.9 million from $1.2 million in the prior year.
• The company recorded a significant goodwill impairment charge of $323.5 million for the three and nine months ended September 30, 2026.
• Management has concluded that substantial doubt exists about the company's ability to continue as a going concern within one year.
• The company is undergoing a strategic repositioning, focusing on Accelsius and reducing parent-level expenses.
• Innventure received a notice from Nasdaq regarding the minimum bid price requirement and is working to regain compliance.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as negative due to significant goodwill impairment charges, substantial net losses, and a going concern warning, despite some revenue growth.

Positives

• Revenue increased by 177.3% to $1.5 million for the three months ended September 30, 2026, compared to $0.5 million in the prior year.
• Revenue increased by approximately 214% to $3.9 million for the nine months ended September 30, 2026, compared to $1.2 million in the prior year.
• General and administrative expenses decreased by 24.1% to $12.8 million for the three months ended September 30, 2026, compared to $16.9 million in the prior year.
• Sales and marketing expenses decreased by 25.4% to $1.9 million for the three months ended September 30, 2026, compared to $2.5 million in the prior year.
• Interest expense, net, decreased significantly by 72.5% to $0.9 million for the three months ended September 30, 2026, compared to $3.4 million in the prior year.
• The company is actively pursuing strategic alternatives for AeroFlexx and Refinity, which could lead to future value realization.
• Innventure has implemented significant parent-level expense reductions, including a 57% reduction in headcount.

Negatives

• The company reported a net loss of $333.8 million for the three months ended September 30, 2026, a substantial increase from the $34.7 million loss in the prior year.
• A significant goodwill impairment charge of $323.5 million was recorded for the three and nine months ended September 30, 2026.
• Management has identified substantial doubt about the company's ability to continue as a going concern within one year.
• The company's cash and cash equivalents decreased from $60.4 million at December 31, 2025, to $22.0 million at September 30, 2026.
• The company received a notice from Nasdaq for failing to meet the minimum bid price requirement, risking delisting.
• Net loss attributable to Innventure, Inc. stockholders was $202.4 million for the three months ended September 30, 2026, compared to $28.3 million in the prior year.
• Adjusted EBITDA was a negative $18.8 million for the three months ended September 30, 2026, compared to a negative $17.5 million in the prior year.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern within one year.
• The company received a notice from Nasdaq for failing to meet the minimum bid price requirement, risking delisting.
• Each of AeroFlexx and Refinity may be required to wind up or cease operations if they cannot obtain other funding.
• The company has a limited number of shares available for future awards under its equity incentive plan, potentially impairing its ability to attract and retain key personnel.
• Sales of a substantial number of shares of common stock, or the perception that such sales may occur, may impair the company's ability to raise capital.
• The company's common stock price may be volatile, and past volatility has led to securities litigation.
• If the company ceases to control and operate the Innventure Companies, its status under the Investment Company Act could be adversely affected.
• The company may be unable to regain compliance with Nasdaq's continued listing requirements.

Future Outlook

The company is undergoing a strategic repositioning, focusing on Accelsius and exploring strategic alternatives for AeroFlexx and Refinity. Management has concluded that substantial doubt exists about the company's ability to continue as a going concern within one year, and liquidity remains a significant concern, with plans to raise capital through various means, including equity sales.

Management Comments

• Innventure builds, scales and operates the companies that it has founded as those companies commercialize new technologies.
• Innventure is focused on preserving and maximizing the value of its operating-company interests for its stockholders through disciplined capital allocation, focused execution, strong governance and strategic initiatives.
• We are primarily concentrating on preserving and increasing the value of our interest in Accelsius and on Accelsius achieving success in the market.
• We have implemented headcount and certain cost reductions at the parent level.
• We intend to defend the action vigorously [referring to the securities class action].

Industry Context

StockSavvy.ai notes that Innventure's focus on technology development and commercialization aligns with industry trends, but the significant goodwill impairment and going concern warning highlight the high-risk nature of early-stage technology ventures and the challenges in scaling operations and achieving profitability in competitive markets.

Comparison to Industry Standards

• The company's revenue growth, while positive, is from a very low base, and the substantial net losses and goodwill impairment are concerning compared to more established players in the technology sector.
• The significant negative Adjusted EBITDA indicates a substantial operational cash burn, which is not uncommon for early-stage technology companies but is concerning when compared to companies that have achieved profitability or positive cash flow.
• The ongoing need for external capital raises and the Nasdaq bid price deficiency are critical issues that differentiate Innventure from companies with stable market capitalizations and access to traditional financing.

Legal Proceedings

• A putative securities class action complaint (Labed v. Innventure, Inc., et al.) was filed on August 28, 2026, alleging materially false and misleading statements and omissions.
• Advanced Cooling Technologies, Inc. (ACT) filed a complaint against Accelsius alleging violations of non-competition and confidentiality obligations, misappropriation of trade secrets, unfair competition, and tortious interference. The court granted summary judgment in favor of Accelsius on trade secret claims and in favor of ACT on breach of contract claims, with nominal damages and attorneys fees awarded to ACT. ACT's remaining claims were dismissed.

Related Party Transactions

• Innventure LLC entered into an Equity Interest Transfer Agreement to sell Vital1 LLC to VITAL Hydration Inc. (a related party) for a $2.0 million secured promissory note and assumption of liabilities.
• Innventure earns a 1%-2% management fee for administrative, finance, and accounting services from the Innventus ESG Fund I, L.P. (ESG Fund).

Stakeholder Impact

• Shareholders face potential dilution from ongoing equity issuances and the risk of delisting from Nasdaq.
• Employees may be impacted by continued cost reductions and potential wind-downs of certain subsidiaries.
• Creditors and lenders face increased risk due to the company's going concern status and potential inability to meet debt obligations.

Next Steps

• Regain compliance with Nasdaq's minimum bid price requirement.
• Continue to explore strategic alternatives for AeroFlexx and Refinity, including potential sales or interim third-party financing.
• Focus on preserving and increasing the value of the company's interest in Accelsius.
• Implement further parent-level expense reductions.
• The Strategic Review Committee will continue its evaluation of capital strategies and other strategic matters.
• Accelsius will continue evaluating its private capital formation needs and alternatives.

Key Dates

Recommendation

The company exhibits severe financial distress, evidenced by substantial net losses, significant goodwill impairment, a going concern warning, and a Nasdaq bid price deficiency. While there is some revenue growth and strategic repositioning, these positives are overshadowed by the overwhelming negatives, making it a high-risk investment.

Keywords

goodwill impairment, going concern, revenue growth, Nasdaq bid price, strategic review, equity financing, cash flow, net loss